findmyKOL

Rohit Adyanthaya, MD

Basic profile

Eastern Virginia Medical School

ORCIDNone on fileNPI
RegionNorfolk, VA · SoutheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rohit Adyanthaya is an Ophthalmology physician affiliated with Eastern Virginia Medical School. OpenAlex indexes 31 publications with 357 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex.

357citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
26companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

241 Corporate Blvd
Norfolk, VA 235024975

Telephone

757-622-2200

Registry record last updated 17 Feb 2019.

View the NPPES registry record

Industry payments

26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    61.8%
    Complement Inhibitor32%
    Pegcetacoplan100%
    Part B, office-administered57 patients
    Vascular Endothelial Growth Factor Inhibitor29.6%
    Aflibercept94%Bevacizumab6%
    Part B, office-administered489 patients

    + 1 more class in this area

  • Sensory organs

    37.3%
    Antineovascularisation agents20.8%
    Faricimab-svoa100%
    Part B, office-administered23 patients
    Complement Inhibitor9.7%
    Avacincaptad pegol100%
    Part B, office-administered34 patients

    + 8 more classes in this area

  • Musculoskeletal

    0.4%
    Cyclooxygenase Inhibitor0.2%
    Ketorolac Tromethamine100%
    Part D24 patients
    Nonsteroidal Anti-inflammatory Drug0.1%
    Diclofenac Sodium100%
    Part D11 patients
Where care is delivered (Part B)0.2% facility · 99.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”